Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kernt

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 23, 2011
[Measurement of glaucoma-specific functionality with the GQL-15 and correlation with parameters of visual function]C Hirneiss, M Vogel, A Kampik, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 27, 2007
[Bevacizumab is not toxic to human anterior- and posterior-segment cultured cells]M Kernt, U Welge-Lüssen, A Yu, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 23, 2013
Attenuation of human lens epithelial cell spreading, migration and contraction via downregulation of the PI3K/Akt pathwayR Liegl, C Wertheimer, M Kernt, et al.
Current Eye Research|March 5, 2014
EGFR-blockade with erlotinib reduces EGF and TGF-β2 expression and the actin-cytoskeleton which influences different aspects of cellular migration in lens epithelial cellsC Wertheimer, R Liegl, M Kernt, et al.
Eye (London, England)|December 21, 2013
Response to Hernández-Martínez et alW J Mayer, A Wolf, M Kernt, et al.
Eye (London, England)|April 20, 2013
Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusionW J Mayer, A Wolf, M Kernt, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 19, 2013
EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacificationC Wertheimer, R Liegl, M Kernt, et al.
Klinische Monatsblatter Fur Augenheilkunde|March 25, 2011
[The role of light in the developement of RPE degeneration in AMD and potential cytoprotection of minocycline]M Kernt, S Thiele, C Hirneiss, et al.
Klinische Monatsblatter Fur Augenheilkunde|March 20, 2013
[Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety evaluations of axitinib, pazopanib and sorafenib for intraocular use]S Thiele, R G Liegl, S König, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 5, 2010
[Diabetic retinopathy: comparison of the diagnostic features of ultra-widefield scanning laser ophthalmoscopy Optomap with ETDRS 7-field fundus photography]M Kernt, F Pinter, I Hadi, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 23, 2011
[Measurement of glaucoma-specific functionality with the GQL-15 and correlation with parameters of visual function]C Hirneiss, M Vogel, A Kampik, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 27, 2007
[Bevacizumab is not toxic to human anterior- and posterior-segment cultured cells]M Kernt, U Welge-Lüssen, A Yu, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 23, 2013
Attenuation of human lens epithelial cell spreading, migration and contraction via downregulation of the PI3K/Akt pathwayR Liegl, C Wertheimer, M Kernt, et al.
Current Eye Research|March 5, 2014
EGFR-blockade with erlotinib reduces EGF and TGF-β2 expression and the actin-cytoskeleton which influences different aspects of cellular migration in lens epithelial cellsC Wertheimer, R Liegl, M Kernt, et al.
Eye (London, England)|December 21, 2013
Response to Hernández-Martínez et alW J Mayer, A Wolf, M Kernt, et al.
Eye (London, England)|April 20, 2013
Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusionW J Mayer, A Wolf, M Kernt, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 19, 2013
EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacificationC Wertheimer, R Liegl, M Kernt, et al.
Klinische Monatsblatter Fur Augenheilkunde|March 25, 2011
[The role of light in the developement of RPE degeneration in AMD and potential cytoprotection of minocycline]M Kernt, S Thiele, C Hirneiss, et al.
Klinische Monatsblatter Fur Augenheilkunde|March 20, 2013
[Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety evaluations of axitinib, pazopanib and sorafenib for intraocular use]S Thiele, R G Liegl, S König, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 5, 2010
[Diabetic retinopathy: comparison of the diagnostic features of ultra-widefield scanning laser ophthalmoscopy Optomap with ETDRS 7-field fundus photography]M Kernt, F Pinter, I Hadi, et al.
Pageof 3